ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 160 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $177,000 | -30.9% | 97,119 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $256,000 | -47.1% | 97,119 | -27.8% | 0.00% | -66.7% |
| Q1 2021 | $484,000 | +110.4% | 134,470 | +47.3% | 0.00% | +50.0% |
| Q4 2020 | $230,000 | +37.7% | 91,262 | +37.6% | 0.00% | 0.0% |
| Q3 2020 | $167,000 | -26.1% | 66,338 | -3.8% | 0.00% | -33.3% |
| Q2 2020 | $226,000 | +143.0% | 68,959 | +81.6% | 0.00% | +200.0% |
| Q1 2020 | $93,000 | -33.1% | 37,970 | +22.6% | 0.00% | -50.0% |
| Q4 2019 | $139,000 | -4.1% | 30,983 | -8.3% | 0.00% | 0.0% |
| Q3 2019 | $145,000 | -8.2% | 33,778 | +24.4% | 0.00% | -33.3% |
| Q2 2019 | $158,000 | -22.5% | 27,162 | -48.6% | 0.00% | -25.0% |
| Q1 2019 | $204,000 | +102.0% | 52,871 | +12.3% | 0.00% | +33.3% |
| Q4 2018 | $101,000 | +5.2% | 47,069 | +57.2% | 0.00% | +50.0% |
| Q3 2018 | $96,000 | – | 29,939 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 9,709,607 | $51,946,000 | 2.80% |
| MILLER VALUE PARTNERS, LLC | 4,900,721 | $26,219,000 | 1.15% |
| MSD Partners, L.P. | 3,410,500 | $18,246,000 | 0.92% |
| Michael & Susan Dell Foundation | 66,749 | $357,000 | 0.26% |
| Glacier Peak Capital LLC | 68,043 | $364,000 | 0.21% |
| Vident Investment Advisory, LLC | 114,980 | $615,000 | 0.08% |
| SFMG, LLC | 62,433 | $334,000 | 0.07% |
| Virtus ETF Advisers LLC | 40,359 | $216,000 | 0.06% |
| Steward Partners Investment Advisory, LLC | 23,187 | $124,000 | 0.06% |
| O'Dell Group, LLC | 10,142 | $54,000 | 0.05% |